Thursday, April 19, 2012 10:49:17 AM
another major drug company could come in with
a more substantial offer. remember, even though
they would not have total rights and profits, they would
have 50% share of -gsk- profits.
that would " in my opinion," twist -gsk- arm to increase
they're bid substantially, just to deter potential buyers.
i think this share price will go to $20. to $25.
it will be interesting to watch.
" I COULD BE WRONG!!"
just remember: this stock was trading at $30.00
exactly one year ago. { 52 week high - 4/28/11
From: Kevin Hyatt <Kevin.Hyatt@comporium.com>
To: Robert Chaney <robertchaneygto@yahoo.com>
Sent: Thursday, April 19, 2012 10:07 AM
Subject: GlaxoSmithKline pounces on Human Genome with $2.6 billion bid
I thought you might be interested in this:
http://reut.rs/IAuCxJ
I found this using the Thomson Reuters News Pro for iPhone app.
To install News Pro on your iPhone or iPad, visit:
http://reuters.com/mobile
Have a great day,
Kevin
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM